← back to search

John E.J. Rasko

The University of Sydney · AU
Area of research
Molecular Biology · Genetics
Research interest
Research interests include RNA modifications and cancer, RNA Research and Splicing, Virus-based gene therapy research, and CAR-T cell therapy research.
h-index
68
citations
19,675
works
421
NIH funding
primary concept
email

Recent publications

Neoadjuvant triplet immune checkpoint blockade in newly diagnosed glioblastoma
Nature Medicine 2025cited by 55position: middledoi
Fidanacogene Elaparvovec for Hemophilia B — A Multiyear Follow-up Study
New England Journal of Medicine 2025cited by 18position: firstdoi
Delphi-driven consensus definition for mesenchymal stromal cells and clinical reporting guidelines for mesenchymal stromal cell–based therapeutics
Cytotherapy 2024cited by 67position: middledoi
Understanding AAV vector immunogenicity: from particle to patient
Theranostics 2024cited by 64position: lastdoi
Global seroprevalence of neutralizing antibodies against adeno-associated virus serotypes used for human gene therapies
Molecular Therapy — Methods & Clinical Development 2024cited by 52position: lastdoi
Two-year safety outcomes of iPS cell-derived mesenchymal stromal cells in acute steroid-resistant graft-versus-host disease
Nature Medicine 2024cited by 27position: lastdoi
Evolutionary dynamics of whole-body regeneration across planarian flatworms
Nature Ecology & Evolution 2023cited by 63position: middledoi
SpliceWiz: interactive analysis and visualization of alternative splicing in R
Briefings in Bioinformatics 2023cited by 32position: middledoi
The next wave of cellular immunotherapies in pancreatic cancer
Molecular Therapy — Oncolytics 2022cited by 77position: lastdoi
Recent advances in cancer fusion transcript detection
Briefings in Bioinformatics 2022cited by 59position: middledoi
Exploring the Clinical Utility of Pancreatic Cancer Circulating Tumor Cells
International Journal of Molecular Sciences 2022cited by 53position: lastdoi
Locoregional delivery of CAR-T cells in the clinic
Pharmacological Research 2022cited by 48position: lastdoi
Illuminating the dark protein-protein interactome
Cell Reports Methods 2022cited by 43position: lastdoi
Mapping oncogenic protein interactions for precision medicine
International Journal of Cancer 2022cited by 28position: lastdoi
Multiyear Factor VIII Expression after AAV Gene Transfer for Hemophilia A
New England Journal of Medicine 2021cited by 251position: middledoi
Anti-Mesothelin CAR T cell therapy for malignant mesothelioma
Biomarker Research 2021cited by 101position: lastdoi
Mesenchymal Stromal Cells for the Treatment of Graft Versus Host Disease
Frontiers in Immunology 2021cited by 98position: lastdoi
CTCF as a regulator of alternative splicing: new tricks for an old player
Nucleic Acids Research 2021cited by 75position: lastdoi
Unique protein interaction networks define the chromatin remodelling module of the NuRD complex
FEBS Journal 2021cited by 45position: lastdoi
Long-Term Follow-Up of the First in Human Intravascular Delivery of AAV for Gene Transfer: AAV2-hFIX16 for Severe Hemophilia B
Molecular Therapy 2020cited by 205position: middledoi
Surveying brain tumor heterogeneity by single-cell RNA-sequencing of multi-sector biopsies
National Science Review 2020cited by 191position: middledoi
Journey to the Center of the Cell: Tracing the Path of AAV Transduction
Trends in Molecular Medicine 2020cited by 111position: lastdoi
Macrophage development and activation involve coordinated intron retention in key inflammatory regulators
Nucleic Acids Research 2020cited by 82position: middledoi
The changing paradigm of intron retention: regulation, ramifications and recipes
Nucleic Acids Research 2019cited by 184position: lastdoi
The Immune Microenvironment in Mesothelioma: Mechanisms of Resistance to Immunotherapy
Frontiers in Oncology 2019cited by 70position: lastdoi
Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia
New England Journal of Medicine 2018cited by 656position: middledoi
Cell, tissue and gene products with marketing authorization in 2018 worldwide
Cytotherapy 2018cited by 108position: middledoi
Guidelines for whole genome bisulphite sequencing of intact and FFPET DNA on the Illumina HiSeq X Ten
Epigenetics & Chromatin 2018cited by 71position: middledoi
Exosomal lncRNAs and cancer: connecting the missing links
Bioinformatics 2018cited by 62position: middledoi
Safety Following Autologous Transplantation with Lentiglobin Gene Therapy for Transfusion-Dependent β-Thalassemia (TDT) in the Northstar Hgb-204 Study
Biology of Blood and Marrow Transplantation 2018cited by 0position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Justin Wong · The University of Sydney15 papers (2013–2023)Charles G. Bailey · The University of Sydney14 papers (2013–2022)Ulf Schmitz · The University of Sydney10 papers (2016–2023)Jeff Holst · UNSW Sydney7 papers (2013–2017)Amy D. Marshall · Bristol-Myers Squibb (United States)6 papers (2013–2017)Dadi Gao · Harvard University6 papers (2013–2017)Dannel Yeo · Centenary Institute5 papers (2021–2022)Michelle van Geldermalsen · The University of Sydney5 papers (2014–2017)Natalia Pinello · The University of Sydney5 papers (2013–2020)Annora Thoeng · National Hospital for Neurology and Neurosurgery5 papers (2013–2017)Qian Wang · Xi'an Honghui Hospital5 papers (2013–2017)Gary J. Schiller · APLA Health4 papers (2014–2018)Alexis A. Thompson · Children's Hospital of Philadelphia4 papers (2014–2018)Mark C. Walters · UCSF Benioff Children's Hospital4 papers (2014–2018)Suradej Hongeng · Mahidol University4 papers (2014–2018)Rajini Nagarajah · The University of Sydney4 papers (2015–2017)Christof von Kalle · Luxembourg Institute of Health4 papers (2014–2018)Marina Cavazzana · Centre d'Investigation Clinique - Innovation Technologique4 papers (2014–2018)Philippe Leboulch · Brigham and Women's Hospital4 papers (2014–2018)Nicholas Otte · Centenary Institute3 papers (2014–2017)